GLIKNIK INC. logo

GLIKNIK INC. jobs and careers

Baltimore, MD, United States

About GLIKNIK INC.

Gliknik, Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders. Its Immunomodulator Platform involves in off-the-shelf peptide drugs that increase CD4, CD8, and antibody immune responses against cancer; Stradomer Platform produces drugs designed to mimic the eficacy of pooled human intravenousimmunoglobulin; and Stradobody Platform produces compounds that are similar to moncolonal antibodies for tumor cell killing. The company was founded in 2007 and is based in Baltimore, Maryland.

Founded in 2007 by David S. Block and Scott E. Strome.

Founded
2007
Employees
1 to 10
Total funding
$70.1M
Headquarters
Baltimore

Leadership

The top of GLIKNIK INC.'s org chart, with how many people report into each leader.

DBPhoto of David S. Block

David S. Block

Chairman & CEO

2 reports

HOPhoto of Henrik S. Olsen

Henrik S. Olsen

VP, Drug Discovery

1 report